Novel EphA4 Agonists for the Treatment of ALS
Tech ID: 33114 / UC Case 2020-246-0
Background
Amyotrophic lateral sclerosis (ALS) is caused by the degeneration and death of motor neurons (MN). In patients with rapid ALS progression, the receptor tyrosine kinase, EphA4, is overexpressed. Studies have shown the unbound EphA4 causes pro-apoptotic activity and death in MNs. Additionally, EphA4 overexpression has been noted to correlate with the progression and resistance to chemotherapy of several human cancers including gastric, breast, and pancreatic cancers. The design of potent, selective, and effective EphA4 agonistic peptidomimetics may be desirable as therapies for ALS and cancer.
Brief Description
Researchers at the University of California, Riverside (UCR) in collaboration Nationwide Children’s Hospital have developed and characterized small peptidomimetics that act as EphA4 agonists. Given ALS is a heterogeneous disease, astrocytes reprogrammed from the fibroblasts of patients with sporadic and SOD1-linked ALS (iAstrocytes) were cultured with MNs and the UCR/Nationwide EphA4 agonists. As seen in Fig. 1, these small agonistic peptidomimetics decrease MN death in iAstrocytes derived from sporadic ALS (sALS) cells.
![](data:image/png;base64,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)
![](data:image/png;base64,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)
Application
- A potential treatment for ALS and cancer
Patent Status
United States Of America |
Published Application |
20230203096 |
06/29/2023 |
2020-246 |
|
|
Related Materials